303 related articles for article (PubMed ID: 24487785)
1. Tissue prognostic biomarkers in primary cutaneous melanoma.
Mandalà M; Massi D
Virchows Arch; 2014 Mar; 464(3):265-81. PubMed ID: 24487785
[TBL] [Abstract][Full Text] [Related]
2. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
3. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
4. Melanoma biomarkers: current status and vision for the future.
Larson AR; Konat E; Alani RM
Nat Clin Pract Oncol; 2009 Feb; 6(2):105-17. PubMed ID: 19107110
[TBL] [Abstract][Full Text] [Related]
5. Predictors of sentinel lymph node status of cutaneous melanoma in Serbian patients.
Jokic S; Markovic I; Bukumiric Z; Jokic V; Rakovic M; Tripkovic J; Stojiljkovic D; Spurnic I; Jevric M; Matic M; Dobrosavljevic D
J BUON; 2018; 23(2):468-474. PubMed ID: 29745094
[TBL] [Abstract][Full Text] [Related]
6. Expression of Ki-67 and Estrogen Receptor Beta in Primary Cutaneous Melanoma as a Potential Indicator of Regional Lymph Node Positivity.
Udovicic-Gagula D; Ahmovic A; Bilalovic N; Doric M
Appl Immunohistochem Mol Morphol; 2019 Jan; 27(1):27-32. PubMed ID: 28549035
[TBL] [Abstract][Full Text] [Related]
7. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
[TBL] [Abstract][Full Text] [Related]
8. Development of a tissue array for primary melanoma with long-term follow-up: discovering melanoma cell adhesion molecule as an important prognostic marker.
Pacifico MD; Grover R; Richman PI; Daley FM; Buffa F; Wilson GD
Plast Reconstr Surg; 2005 Feb; 115(2):367-75. PubMed ID: 15692338
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: A retrospective cohort study.
Ipenburg NA; Lo SN; Vilain RE; Holtkamp LHJ; Wilmott JS; Nieweg OE; Thompson JF; Scolyer RA
J Am Acad Dermatol; 2020 Apr; 82(4):910-919. PubMed ID: 31682859
[TBL] [Abstract][Full Text] [Related]
10. EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.
Caudron A; Battistella M; Feugeas JP; Pages C; Basset-Seguin N; Mazouz Dorval S; Funck Brentano E; Sadoux A; Podgorniak MP; Menashi S; Janin A; Lebbé C; Mourah S
Exp Dermatol; 2016 Aug; 25(8):618-22. PubMed ID: 27060463
[TBL] [Abstract][Full Text] [Related]
11. A multimarker prognostic assay for primary cutaneous melanoma.
Kashani-Sabet M; Venna S; Nosrati M; Rangel J; Sucker A; Egberts F; Baehner FL; Simko J; Leong SP; Haqq C; Hauschild A; Schadendorf D; Miller JR; Sagebiel RW
Clin Cancer Res; 2009 Nov; 15(22):6987-92. PubMed ID: 19887476
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
[TBL] [Abstract][Full Text] [Related]
14. External validation of a prognostic model to predict survival of patients with sentinel node-negative melanoma.
Ipenburg NA; Nieweg OE; Ahmed T; van Doorn R; Scolyer RA; Long GV; Thompson JF; Lo S
Br J Surg; 2019 Sep; 106(10):1319-1326. PubMed ID: 31310333
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of non-sentinel lymph node metastasis in cutaneous and acral melanoma patients-A multicenter retrospective study.
Sun W; Xu Y; Yang J; Liao Z; Li T; Huang K; Patel P; Yan W; Chen Y
Cancer Commun (Lond); 2020 Nov; 40(11):586-597. PubMed ID: 33025763
[TBL] [Abstract][Full Text] [Related]
16. Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.
Sheen YS; Liao YH; Lin MH; Chiu HC; Jee SH; Liau JY; Chang YL; Chu CY
PLoS One; 2016; 11(1):e0147431. PubMed ID: 26796627
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
18. Melanoma prognosis: a REMARK-based systematic review and bioinformatic analysis of immunohistochemical and gene microarray studies.
Schramm SJ; Mann GJ
Mol Cancer Ther; 2011 Aug; 10(8):1520-8. PubMed ID: 21659462
[TBL] [Abstract][Full Text] [Related]
19. Melanoma biomarkers: current status and utility in diagnosis, prognosis, and response to therapy.
Haass NK; Smalley KS
Mol Diagn Ther; 2009; 13(5):283-96. PubMed ID: 19791833
[TBL] [Abstract][Full Text] [Related]
20. Transcription factors and other dysregulated proteins in melanoma prognosis.
Karjalainen JM
Curr Oncol Rep; 2001 Jul; 3(4):368-75. PubMed ID: 11389823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
